Fanouriakis, A. Et Al. 2018. In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: A retrospective cohort study. Clinical and Experimental Rheumatology , vol.36, no.5 , 806-813.

Fanouriakis, A., Papalopoulos, I., Gergianaki, I., Spyrou, G., Erden, A., Rapsomaniki, P., ... Terizaki, M.(2018). In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: A retrospective cohort study. Clinical and Experimental Rheumatology , vol.36, no.5, 806-813.

Fanouriakis, Antonis Et Al. "In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: A retrospective cohort study," Clinical and Experimental Rheumatology , vol.36, no.5, 806-813, 2018

Fanouriakis, Antonis Et Al. "In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: A retrospective cohort study." Clinical and Experimental Rheumatology , vol.36, no.5, pp.806-813, 2018

Fanouriakis, A. Et Al. (2018) . "In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: A retrospective cohort study." Clinical and Experimental Rheumatology , vol.36, no.5, pp.806-813.

@article{article, author={Antonis Fanouriakis Et Al. }, title={In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: A retrospective cohort study}, journal={Clinical and Experimental Rheumatology}, year=2018, pages={806-813} }